Endo International PLC (OTC Pink - Current Information:ENDPQ)

0.0975
Delayed Data
As of Jan 27
 -0.0032 / -3.18%
Today’s Change
0.06
Today|||52-Week Range
3.49
+37.71%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$22.9M

Company Description

Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment's operations are currently conducted through Paladin's leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

Contact Information

Endo International Plc
Minerva House
Dublin Dublin 4
P:(531) 268-2000
Investor Relations:
(845) 364-4833

Employees

Shareholders

Mutual fund holders3.10%
Individual stakeholders2.29%
Other institutional0.02%

Top Executives

Blaise A ColemanPresident, Chief Executive Officer & Director
Robert PolkeExecutive VP & Global Head-Operations
Mark BradleyChief Financial Officer & Executive Vice President
Ruth ThorpeChief Information Officer
James Patrick TursiExecutive VP-Global Research & Development